Main Topics

Adjuvant treatment options in HER2-positive breast cancer.
Recent management of metastatic TND breast cancer. (Joyce)
Best sequence of anti-HER2 therapy for MBC patients.
Adjuvant hormonal therapy in premenopausal breast cancer patients: what is the standard?
Implication of TND MBC sub-classification in management options.
Neo-adjuvant hormonal therapy in postmenopausal breast cancer patients.
Neo-adjuvant therapy options in HER2 positive breast cancer patients.
Overcoming resistance to anti-HER2 therapy.
Best sequence of therapy in Luminal MBC.
Overcoming resistance of hormonal therapy in MBC setting.
Management of inflammatory breast cancer.
Role of liquid biopsy and implication in the treatment.
Breast cancer micro-environment: a target for therapy.
Role of local management in MBC.
Parp inhibitors: present and future. (pascal)
Fertility issues in young women with breast cancer.
Special consideration for management of breast cancer in geriatric patients. (matti)
Special situation in MBC:
Bone only metastasis.
Brain only metastasis.
Treatment of BRCA 1/2 mutant breast cancer patients.
CDK4/6 (nuhad)
Can we get away with less neoadjuvant chemotherapy? (nuhad)
The immune system – a guide to basic immunology
Introduction to immunotherapies and clinical data
Overview of recent progress of immunotherapy in cancer
Melanoma as a model disease for immunotherapy
Non-small Lung cancer
Immunotherapy-changing the future
Small cell lung cancer
Bladder cancer: going the distance
New data in breast cancer
Inside the debate of breast cancer: to screen or not?
Breast Cancer Screening protocols for high risk individuals
Abbreviated MRI screening (new trend saves time and lives)Does 3D Tomosynthesis improve breast cancer detection?
Missed breast Carcinoma: Why and how to avoid?
Supplementary screening using hand held and automated breast ultrasound
Adding the Merits of contrast to the Ease of Mammography: Can We Highlight What's Behind Breast Asymmetries?
Multidisciplinary Breast Cancer tumor boards: an Opportunity for Radiologists to Declare Value and Establish Communications.
Imaging Evaluation of Breast Symptoms
Mammography BIRADS lexicon; a common language to communicate in the multidisciplinary breast team
Role of Ultrasound in the diagnosis and loco regional staging of breast cancer
MRI from indications to interpretation.
Post breast cancer surveillance protocols
Follow-up of patients under neo-adjuvant chemotherapy.
PET CT in the diagnosis and staging of female pelvic malignancies
A practical approach to female pelvic malignancies
Cervical Carcinoma from screening, through diagnosis, to post treatment surveillance
Ovarian Cancer Screening – Ultrasound; Impact on Ovarian Cancer Mortality
Management of node positive cervical cancer.
Proton therapy for carcinoma of uterine cervix
Image-guided brachytherapy in gynecological cancers: treatment technique and clinical outcomes
Management of advanced endometrial cancer
IMRT in gynecological cancer treatment.
Breath holding technique during radiotherapy of the breast
Intra operative contact x ray 50 Kev brachytherapy for early breast cancer
Role of interstitial brachytherapy in the treatment of primary or recurrent breast cancer:
patient selection and technique considerations.
Proton therapy for breast cancer treatment.
Updates in radiosurgical management of brain metastasis of breast origin
Major Changes in the AJCC 8th Edition Cancer Staging.
Apocrine Lesions of the Breast.
Molecular characterization of pleomorphic lobular carcinoma in situ in comparison to high grade ductal carcinoma in situ".
Pseudoinvasive lesios of the breast.
interesting and challenging breast pathology cases.
Diagnostic challenges and pitfall: Cervical intraepithelial Neoplasia.
Endocervical adenocarcinoma: Silva system and IECC classification.
Overview of Neoplastic Vulvar Lesions.
Challenging Pap Smears: Cytology/Histology Correlation.
Overview Non- neoplastic Vulvar Lesion.
Endometrial Biopsy Interpretation and Differential Diagnosis.
Problems in the Diagnosis of Molar Pregnancies.
Interesting and challenging GYN pathology cases.
State of the art management options of the most common gynaecological malignancies .
Treatment individualisation and decision making pathways based on the latest evidence addressing
the needs for fertility preservation.
Controversies in the management of ovarian, endometrial and cervical cancers “meet the expert session”
Optimizing treatment and referral pathways of gynaecological cancer patients in Egypt.
How to minimize the adverse effects of chemotherapy and radiotherapy.
Will Biosimilars change the cancer landscape in Egypt.
From problem to success towards health promotion and chemoprevention
Nutrition and cancer what you need to know
CACS: Introduction
Ghrelin receptor agonists for CACS
Nutritional support in CACS patients
Other pharmacological treatment options for CACS
Mirtazapine for CACS: placebo-controlled randomized clinical trial protocol
Understandability of the Arabic version of the Functional assessment of anorexia-cachexia therapy
(FAACT) scale by Egyptian cancer patients
Infection as critical condition in cancer patient
Nursing care of oral mucositis
Improve the safety and quality of care
Nursing care of neutropenia
Primary nurse assessment
Nursing care of patient receiving radiotherapy
Tumor Lysis Syndrome
Efficacy of arthropod venoms against cancer
Biodegradable nano polymer drug carriers for cancer therapy
Relieving pain postmastectomy: Effect of Nursing Intervention
Stressors and coping strategies among family caregivers having children with lymphoma
Improving self-efficacy for optimized cancer patient outcomes-

© Copyright All rights reserved by BGICC